Anna Alina Itkonen

About me

I am a Postdoctoral Researcher in Anna Beronius' group at the Institute of Environmental Medicine, KI, in the field of regulatory toxicology.

My current research develops new approaches to the assessment and identification of endocrine disrupting chemicals (EDCs), with a particular focus on adverse outcome pathways (AOPs) relevant for regulatory assessment.
I hold a PhD in Toxicology. My doctoral research applied metabolomics to investigate the metabolic effects of SSRI use during pregnancy.

Journal article: EUROPEAN JOURNAL OF MEDICAL RESEARCH. 2026;31(1):258
Metabolomic insights: LC-MS profiling of human placental tissue from SSRI-treated pregnancies.
Itkonen A; Kärkkäinen O; Lehtonen M; Sahlman H; Keski-Nisula L; Rysä J
Journal article: 2025
Myrkytystietokeskukseen raportoidut syanotoksiinien aiheuttamat oireet
Itkonen A; Pusenius M; Niittynen M; Rysä J
Journal article: METABOLOMICS. 2025;21(5):123
Longitudinal metabolic profiling of women using selective serotonin reuptake inhibitors during pregnancy
Itkonen A; Karkkainen O; Sahlman H; Keski-Nisula L; Rysa J
Journal article: ARCHIVES OF TOXICOLOGY. 2023;97(11):2861-2877
Adverse outcome pathway for pregnane X receptor-induced hypercholesterolemia
Itkonen A; Hakkola J; Rysa J
Journal article: PLACENTA. 2022;129:30-35
Altered activities of CYP1A1 and CYP19A1 enzymes in women using SSRI medication during pregnancy
Sahlman H; Itkonen A; Lehtonen M; Keski-Nisula L; Rysa J

Postdoctoral Researcher, Institute of Environmental Medicine, Karolinska Institutet, 2026-2028

PhD, Toxicology, Metabolic effects of selective serotonin reuptake inhibitors during pregnancy, School of Pharmacy, University of Eastern Finland, 2025